Biodegradable Branched Polyesters Poly(vinyl sulfonate-covinyl alcohol)-graft Poly(d,l-lactic-coglycolic acid) as a Negatively Charged Polyelectrolyte Platform for Drug Delivery: Synthesis and Characterization

Promising Role of Polylactic Acid as an Ingenious Biomaterial in Scaffolds, Drug Delivery, Tissue Engineering, and Medical Implants: Research Developments, and Prospective Applications

In the present scenario, the research is now being focused on the naturally occurring polymers that can gradually replace the existing synthetic polymers for the development of bio composites having applications in medical surgeries and human implants. With promising mechanical properties and bio compatibility with human tissues, poly lactic acid (PLA) is now being viewed as a future bio material. In order to examine the applicability of PLA in human implants, the current article sheds light on the synthesis of PLA and its various copolymers used to alter its physical and mechanical properties. In the latter half, various processes used for the fabrication of biomaterials are discussed in detail. Finally, biomaterials that are currently in use in the field of biomedical (Scaffolding, drug delivery, tissue engineering, medical implants, derma, cosmetics, medical surgeries, and human implants) are represented with respective advantages in the sphere of biomaterials.

Strong Antimicrobial Activity of Highly Stable Nanocomposite Containing AgNPs Based on Water-Soluble Triazole-Sulfonate Copolymer

A new hydrophilic polymeric nanocomposite containing AgNPs was synthesized by chemical reduction of metal ions in an aqueous medium in the presence of the copolymer. A new water-soluble copolymer of 1-vinyl-1,2,4-triazole and vinylsulfonic acid sodium salt (poly(VT-co-Na-VSA)) was obtained by free-radical copolymerization and was used as a stabilizing precursor agent. The structural, dimensional, and morphological properties of the nanocomposite were studied by UV–Vis, FTIR, X-ray diffraction, atomic absorption, transmission and scanning electron microscopy, dynamic and electrophoretic light scattering, gel permeation chromatography, thermogravimetric analysis, and differential scanning calorimetry. Hydrodynamic diameter of macroclubs for the copolymer was 171 nm, and for the nanocomposite it was 694 nm. Zeta potential for the copolymer was −63.8 mV, and for the nanocomposite it was −70.4 mV. The nanocomposite had strong antimicrobial activity towards Gram-negative and Gram-positive microorganisms: MIC and MBC values were in the range of 0.25–4.0 and 0.5–8.0 μg/mL, respectively.

Polymers from S-vinyl monomers: reactivities and properties

This review summarises the work of several decades on the polymerisation of S-vinyl monomers, ranging from the early reports of suitable polymerisation techniques for these monomers to their recent renaissance in various applications.

Green Copolymers Based on Poly(Lactic Acid)-Short Review

Polylactic acid (PLA) is a biodegradable and biocompatible polymer that can be applied in the field of packaging and medicine. Its starting substrate is lactic acid and, on this account, PLA can also be considered an ecological material produced from renewable resources. Apart from several advantages, polylactic acid has drawbacks such as brittleness and relatively high glass transition and melting temperatures. However, copolymerization of PLA with other polymers improves PLA features, and a desirable material marked by preferable physical properties can be obtained. Presenting a detailed overview of the accounts on the PLA copolymerization accomplishments is the innovation of this paper. Scientific findings, examples of copolymers (including branched, star, grafted or block macromolecules), and its applications are discussed. As PLA copolymers can be potentially used in pharmaceutical and biomedical areas, the attention of this article is also placed on the advances present in this field of study. Moreover, the subject of PLA synthesis is described. Three methods are given: azeotropic dehydrative condensation, direct poly-condensation, and ring-opening polymerization (ROP), along with its mechanisms. The applied catalyst also has an impact on the end product and should be adequately selected depending on the intended use of the synthesized PLA. Different ways of using stannous octoate (Sn(Oct)₂) and examples of the other inorganic and organic catalysts used in PLA synthesis are presented.

Antimicrobial Activity of Electrospun Polyvinyl Alcohol Nanofibers Filled with Poly[2-(tert-butylaminoethyl) Methacrylate]-Grafted Graphene Oxide Nanosheets

A novel cationic polymer, poly[2-(tert-butylaminoethyl) methacrylate] (PTA), effectively kills various strains of bacteria with low toxicity to tissue cells. Graphene-based materials demonstrate exceptional electron transport capability, antibacterial activity, favorable nontoxicity, and versatile applicability. PTA can be grafted onto the graphene oxide (GO) surface (GO-g-PTA) to enhance the antimicrobial efficiency of the latter against Staphylococcus aureus (S. aureus). In this study, GO-g-PTA powders were successfully synthesized via free radical polymerization (GO-g-PTA-F) and atom transfer radical polymerization (GO-g-PTA-A). The antimicrobial efficiencies of graphene nanosheets (GNSs), GO-g-PTA-F, and GO-g-PTA-A were then investigated. Addition of GNS, GO-g-PTA-F, and GO-g-PTA-A to the PVA nanofibers was carried out elucidate the effects of filler amount and physical treatment on the morphology, microstructure, crystallization behaviors, antimicrobial efficiency, and cytotoxicity of the composite fibers. Finally, the potential applications of electrospun PVA/GNS, PVA/GO-g-PTA-F, and PVA/GO-g-PTA-A composite nanofiber mats to chronic wound care were evaluated. The resulting PVA/GO-g-PTA-A composite nanofiber mats showed enhanced antimicrobial ability against S. aureus compared with the PVA/GNS and PVA/GO-g-PTA-F composite nanofiber mats at the same filler volume percentage.

Synergistic Effect and Characterization of Graphene/Carbon Nanotubes/Polyvinyl Alcohol/Sodium Alginate Nanofibrous Membranes Formed Using Continuous Needleless Dynamic Linear Electrospinning

In this study, a self-made continuous needleless dynamic linear electrospinning technique is employed to fabricate large-scale graphene (Gr)/carbon nanotubes (CNT)/polyvinyl alcohol (PVA)/sodium alginate (SA) nanofibrous membranes. The synergistic effect of Gr and CNT fillers in the PVA/SA membrane is explored in depth by changing the volume ratio (v/v) of Gr and CNT as 10:0, 8:2, 6:4, 4:6, 2:8, and 0:10. Microstructure, functional group, conductivity, and hydrophilicity of PVA/SA/Gr/CNT membranes was characterized. Results show that the linear electrode needleless electrospinning technique can be spun into 200-nm diameter fibers. The PVA/SA/Gr/CNT fibrous membrane has good hydrophilicity and thermal stability. A Gr/CN ratio of 6:4 possessed the optimal synergistic effect, which showed the lowest surface resistivity of 2.53 × 103 Ω/m2. This study will provide a reference for the large-scale preparation of nanofibrous membrane used as a artificial nerve conduit in the future.

Characterization and Microstructure of Linear Electrode-Electrospun Graphene-Filled Polyvinyl Alcohol Nanofiber Films

With the aim of achieving controllable mass production of electrospun nanofiber films, this study proposes and investigates the feasibility of using a custom-made linear electrode- electrospun device to produce conductive graphene (GR)-filled polyvinyl alcohol (PVA) nanofibers. The film morphology and diameter of nanofibers are observed and measured to examine the effects of viscosity and conductivity of the PVA/GR mixtures. Likewise, the influence of the content of graphene on the hydrophilicity, electrical conductivity, electromagnetic interference shielding effectiveness (EMSE), and thermal stability of the PVA/GR nanofiber films is investigated. The test results show that the PVA/GR mixture has greater viscosity and electric conductivity than pure PVA solution and can be electrospun into PVA/GR nanofiber films that have good morphology and diameter distribution. The diameter of the nanofibers is 100 nm and the yield is 2.24 g/h, suggesting that the process qualifies for use in large-scale production. Increasing the content of graphene yields finer nanofibers, a smaller surface contact angle, and higher hydrophilicity of the nanofiber films. The presence of graphene is proven to improve the thermal stability and strengthens the EMSE by 20 dB at 150–1500 MHz. Mass production is proven to be feasible by the test results showing that PVA/GR nanofiber films can be used in the medical hygiene field.

Polymeric nanoparticles in development for treatment of pulmonary infectious diseases

Serious lung infections, such as pneumonia, tuberculosis, and chronic obstructive cystic fibrosis-related bacterial diseases, are increasingly difficult to treat and can be life-threatening. Over the last decades, an array of therapeutics and/or diagnostics have been exploited for management of pulmonary infections, but the advent of drug-resistant bacteria and the adverse conditions experienced upon reaching the lung environment urge the development of more effective delivery vehicles. Nanotechnology is revolutionizing the approach to circumventing these barriers, enabling better management of pulmonary infectious diseases. In particular, polymeric nanoparticle-based therapeutics have emerged as promising candidates, allowing for programmed design of multi-functional nanodevices and, subsequently, improved pharmacokinetics and therapeutic efficiency, as compared to conventional routes of delivery. Direct delivery to the lungs of such nanoparticles, loaded with appropriate antimicrobials and equipped with 'smart' features to overcome various mucosal and cellular barriers, is a promising approach to localize and concentrate therapeutics at the site of infection while minimizing systemic exposure to the therapeutic agents. The present review focuses on recent progress (2005-2015) important for the rational design of nanostructures, particularly polymeric nanoparticles, for the treatment of pulmonary infections with highlights on the influences of size, shape, composition, and surface characteristics of antimicrobial-bearing polymeric nanoparticles on their biodistribution, therapeutic efficacy, and toxicity. WIREs Nanomed Nanobiotechnol 2016, 8:842-871. doi: 10.1002/wnan.1401 For further resources related to this article, please visit the WIREs website.

Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension

Direct vasodilator delivery to the airways enables a selective therapy of pulmonary hypertension (PH). However, short-term effects of the applied medication require multiple daily inhalations. Controlled release formulations (polymeric nanomedicines) offer the potential of prolonging drug effects within the respiratory tract, thereby reducing the number of necessary inhalations. In the model of U46619-elicited PH, sildenafil and two sildenafil-loaded polymeric submicron particle formulations were evaluated for their pharmacodynamic and pharmacokinetic characteristics and acute tolerability. Lung-delivered sildenafil caused a selective dose-dependent decline of the pulmonary arterial pressure and vascular resistance. Compared to the transient pharmacodynamic effect observed for sildenafil, the same dose of nanoencapsulated sildenafil resulted in prolongation, but not augmentation, of the pulmonary vasodilatation. An extended pharmacokinetic profile was observed for nanoencapsulated sildenafil, and nanomedicines revealed no acute toxicity. The amplification of pulmonary vasodilatory response caused by nanoencapsulation of sildenafil offers an intriguing approach to ameliorate the therapy of PH. From the Clinical Editor: Pulmonary hypertension usually results in right heart failure long term. Current medical therapy includes the use of potent vasodilators such as sildenafil. In this article, the authors investigated the use of nanoencapsulated formulation for sustained delivery via inhalation route. An extended pharmacokinetic profile was seen for this nanoformulation with little side effects. It is hoped that clinical application of this would come to fruition soon.

Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide)

The development of well-defined polymeric nanoparticles (NPs) as delivery carriers for antimicrobials targeting human infectious diseases requires rational design of the polymer template, an efficient synthetic approach, and fundamental understanding of the developed NPs, e.g., drug loading/release, particle stability, and other characteristics. Herein, we developed and evaluated the in vitro antimicrobial activity of silver-bearing, fully biodegradable and functional polymeric NPs. A series of degradable polymeric nanoparticles (dNPs), composed of phosphoester and L-lactide and designed specifically for silver loading into the hydrophilic shell and/or the hydrophobic core, were prepared as potential delivery carriers for three different types of silver-based antimicrobials-silver acetate or one of two silver carbene complexes (SCCs). Silver-loading capacities of the dNPs were not influenced by the hydrophilic block chain length, loading site (i.e., core or shell), or type of silver compound, but optimization of the silver feed ratio was crucial to maximize the silver loading capacity of dNPs, up to ca. 12% (w/w). The release kinetics of silver-bearing dNPs revealed 50% release at ca. 2.5-5.5 h depending on the type of silver compound. In addition, we undertook a comprehensive evaluation of the rates of hydrolytic or enzymatic degradability and performed structural characterization of the degradation products. Interestingly, packaging of the SCCs in the dNP-based delivery system improved minimum inhibitory concentrations up to 70%, compared with the SCCs alone, as measured in vitro against 10 contemporary epidemic strains of Staphylococcus aureus and eight uropathogenic strains of Escherichia coli. We conclude that these dNP-based delivery systems may be beneficial for direct epithelial treatment and/or prevention of ubiquitous bacterial infections, including those of the skin and urinary tract.

Advances in device and formulation technologies for pulmonary drug delivery

Inhaled pharmaceuticals are formulated and delivered differently according to the therapeutic indication. However, specific device-formulation coupling is often fickle, and new medications or indications also demand new strategies. The discontinuation of chlorofluorocarbon propellants has seen replacement of older metered dose inhalers with dry powder inhaler formulations. High-dose dry powder inhalers are increasingly seen as an alternative dosage form for nebulised medications. In other cases, new medications have completely bypassed conventional inhalers and been formulated for use with unique inhalers such as the Staccato® device. Among these different devices, integration of software and electronic assistance has become a shared trend. This review covers recent device and formulation advances that are forming the current landscape of inhaled therapeutics.

Controlled pulmonary drug and gene delivery using polymeric nano-carriers

Pulmonary drug and gene delivery to the lung represents a non-invasive avenue for local and systemic therapies. However, the respiratory tract provides substantial barriers that need to be overcome for successful pulmonary application. In this regard, micro- and nano-sized particles offer novel concepts for the development of optimized therapeutic tools in pulmonary research. Polymeric nano-carriers are generally preferred as controlled pulmonary delivery systems due to prolonged retention in the lung. Specific manipulation of nano-carrier characteristics enables the design of "intelligent" carriers specific for modulation of the duration and intensity of pharmacological effects. New formulations should be tested for pulmonary absorption and distribution using more advanced ex vivo and in vivo models. The delivery of nano-carriers to the air-space enables a detailed characterization of the interaction between the carrier vehicle and the natural pulmonary environment. In summary, polymeric nanoparticles seem to be especially promising as controlled delivery systems and represent a solid basis for future advancement for pulmonary delivery applications.

Mesoscopic simulations on the aggregation behavior of pH-responsive polymeric micelles for drug delivery

Computer simulations, dissipative particle dynamics (DPD) and mesoscopic dynamics (MesoDyn), are performed to study the aggregation behavior of pH-sensitive micelles self-assembled from amphiphilic polymer poly(methyl methacrylate-co-methacrylic acid)-b-poly(poly-(ethylene glycol) methyl ether monomethacrylate), P(MMA-co-MAA)-b-PPEGMA. Ibuprofen (IBU) is selected as the model drug. It can be seen from DPD simulations that P(MMA-co-MAA)-b-PPEGMA and IBU form spherical core-shell micelles at certain compositions, and IBU molecules distribute inside the core formed by hydrophobic MMA. The polymer molecules aggregate first, and then IBU diffuses into the aggregate, forming drug-loaded nanoparticles. With different compositions of polymer and IBU, aggregate morphologies in water are observed as sphere, column and lamella. From MesoDyn results, with less hydrophobic MMA beads, the polymer chains are more difficult to form ordered aggregates, and the order parameters get equilibrated in a longer time. The pH value also affects the aggregate process. At pH<5, the polymer could form traditional core-shell micelles. But at pH>5, the morphology of micelles is found to be anomalous and loose for releasing drug. MAA aggregates on the surface, instead of the inside. The simulation results are qualitatively consistent with the experimental results.

Influence of particle size and material properties on mucociliary clearance from the airways

Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly noxious material from the airways, considerably limits the benefit of inhalation therapy. Although the principles of MC seem to be understood, there are still many open questions on mucociliary particle clearance. In this study a trachea-based in vitro model was used to investigate the effect of particle size, zeta-potential, and mucoadhesive particle properties on mucociliary particle clearance. As different sized particles (50-6000 nm) were tested at equal mass concentrations, size related factors, namely particle number and particle surface area, varied by several orders of magnitude between the experiments. Surprisingly, particle clearance for 50 nm up to 6000 nm-sized polystyrene particles did not differ significantly (p < 0.05): 50 nm (2.9 +/- 0.6 mm/min); 100 nm (3.8 +/- 0.9 mm/min); 1000 nm (3.8 +/- 0.8 mm/min); 6000 nm (3.2 +/- 0.6 mm/min). In clear contrast, particles prepared from different PLGA-based copolymers (polylactic-co-glycolic acid) showed a significant effect on particle transport. PEG-PLGA particles (polyethylene glycol) showed the fastest and normal transport rates (5.9 +/- 1.7 mm/min) compared to the ICRP's (International Commission of Radiological Protection) standard value for average tracheal transport rates (5.5 mm/min). Mucoadhesive chitosan-PLGA particles were transported at the slowest rate (0.7 +/- 0.3 mm/min) of all particles tested. Overall, particle size and zeta-potential seem to be relatively uncritical, whereas material properties and the related particle surface chemistry significantly influence mucociliary particle clearance. Considering these findings in future drug formulation seems to be a promising strategy to improve inhalation therapy by prolonged particle/drug residence time within the airways.

Microthermogravimetry of a single microcapsule using silicon microresonators

A chlorobenzene-containing polyurethane microcapsule was placed on the free end of a silicon cantilever, and the temperature dependence of the resonance frequency was measured. As the cantilever was heated, the resonance frequency showed steplike increases at 109 and 270 degrees C that were due to the rupture of the capsule and the thermal degradation of the polyurethane shell, respectively. The frequency changes due to the rupture of a single capsule measured by the cantilever were much sharper than the transitions measured by conventional thermogravimetric analysis (TGA), which measures the average mass change of a collection of capsules characterized by a large size distribution. When two capsules were placed on the cantilever, their individual rupture temperatures could be clearly identified. In addition, the permeability of the polyurethane shell, with respect to chlorobenzene, was measured, and the rupture temperature was observed to decrease with increasing permeability.

Biodegradable polymeric nanocarriers for pulmonary drug delivery

BACKGROUND

Pulmonary drug delivery is attractive for both local and systemic drug delivery as a non-invasive route that provides a large surface area, thin epithelial barrier, high blood flow and the avoidance of first-pass metabolism.

OBJECTIVE

Nanoparticles can be designed to have several advantages for controlled and targeted drug delivery, including controlled deposition, sustained release, reduced dosing frequency, as well as an appropriate size for avoiding alveolar macrophage clearance or promoting transepithelial transport.

METHODS

This review focuses on the development and application of biodegradable polymers to nanocarrier-based strategies for the delivery of drugs, peptides, proteins, genes, siRNA and vaccines by the pulmonary route.

RESULTS/CONCLUSION

The selection of natural or synthetic materials is important in designing particles or nanoparticle clusters with the desired characteristics, such as biocompatibility, size, charge, drug release and polymer degradation rate.